PERNIX THERAPEUTICS HLDGS IN

Historical 13F Holders

CUSIP
71426VAK4
All holders as of
Q1 2020
Type
Debt
Class
DBCV 4.250% 4/0
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q1 1 0 $0
2019 Q4 1 0 $0
2019 Q3 1 0 $0
2019 Q2 1 0 $0
2019 Q1 3 4.00 M $46.0 k
2018 Q4 13 67.7 M $10.9 M
2018 Q3 13 69.7 M $26.7 M
2018 Q2 12 69.7 M $28.8 M
2018 Q1 12 69.7 M $30.5 M
2017 Q4 13 78.2 M $32.2 M
2017 Q3 13 78.2 M $32.1 M
2017 Q2 14 130 M $37.1 M
2017 Q1 15 138 M $35.3 M
2016 Q4 13 128 M $31.5 M
2016 Q3 15 128 M $35.0 M
2016 Q2 15 128 M $29.0 M